RESEARCH
Check out the latest in PH research news taking place across the globe and right here in Canada: from progress in understanding the science behind PH to developments in early diagnosis, treatment, and improving quality of life.
Sotatercept safe and effective across cardiac index groups
ZENITH study shows sotatercept is effective for PAH patients at high risk of mortality
Update: Canadian Drug Agency Funding Success for Pulmonary Hypertension Research
Rural and urban PH patients receive equivalent care
Sotatercept is now listed on Health Canada's website
Dr. Jason Weatherald Discusses the Burden of PAH on the PHaware Podcast
The FDA has granted approval for the medication sotatercept
The evolving landscape of pulmonary arterial hypertension clinical trials
Medications for the treatment of pulmonary arterial hypertension
Advances in Pulmonary Hypertension: Quality of Life
Social determinants of health in pulmonary arterial hypertension patients in the United States: Clinician perspective and health policy implications
Inhaled Seralutinib Shows Promise in 2 PAH Animal Models
Opsyvni enters pCPA negotiations
Social Media Participation Among Parents and Caregivers of Children With Pulmonary Hypertension
Palliative Care and Pulmonary Arterial Hypertension
BET Protein Inhibition for Pulmonary Arterial Hypertension
